[go: up one dir, main page]

IL131492A0 - Topical nasal antiinflammatory compositions - Google Patents

Topical nasal antiinflammatory compositions

Info

Publication number
IL131492A0
IL131492A0 IL13149298A IL13149298A IL131492A0 IL 131492 A0 IL131492 A0 IL 131492A0 IL 13149298 A IL13149298 A IL 13149298A IL 13149298 A IL13149298 A IL 13149298A IL 131492 A0 IL131492 A0 IL 131492A0
Authority
IL
Israel
Prior art keywords
topical nasal
antiinflammatory compositions
antiinflammatory
compositions
nasal
Prior art date
Application number
IL13149298A
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL131492A0 publication Critical patent/IL131492A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13149298A 1997-04-30 1998-04-02 Topical nasal antiinflammatory compositions IL131492A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4430697P 1997-04-30 1997-04-30
PCT/US1998/006483 WO1998048839A1 (en) 1997-04-30 1998-04-02 Topical nasal antiinflammatory compositions

Publications (1)

Publication Number Publication Date
IL131492A0 true IL131492A0 (en) 2001-01-28

Family

ID=21931638

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13149298A IL131492A0 (en) 1997-04-30 1998-04-02 Topical nasal antiinflammatory compositions

Country Status (8)

Country Link
EP (1) EP0979105A1 (en)
JP (1) JP2001524108A (en)
CN (1) CN1253508A (en)
AU (1) AU6878098A (en)
BR (1) BR9809022A (en)
CA (1) CA2281789A1 (en)
IL (1) IL131492A0 (en)
WO (1) WO1998048839A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT998272E (en) * 1997-08-26 2003-09-30 Aventis Pharma Inc PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT
CN1283115A (en) * 1997-12-23 2001-02-07 先灵公司 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
IT1313567B1 (en) * 1999-07-27 2002-09-09 Zambon Spa USE OF N-ACETYL-CISTEIN FOR THE PREPARATION OF TOPICAL PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ALLERGIC PATHOLOGIES OF
DE10007203A1 (en) * 2000-02-17 2001-08-23 Asta Medica Ag Composition for treating allergic and/or vasomotor rhinitis or allergic conjunctivitis by topical or oral administration, contains synergistic combination of non-sedating antihistamine and leukotriene antagonist
DK1446119T3 (en) 2001-09-18 2006-07-10 Nycomed Danmark Aps Compositions comprising Ipratropium and xylometazoline for the treatment of common cold
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
AU2003278962B2 (en) * 2002-06-20 2006-11-23 Novartis Consumer Health S.A. Nasal compositions comprising a mucopolysaccharide and propylene glycol
ES2393864T3 (en) 2002-08-30 2012-12-28 Nycomed Gmbh The use of the association of ciclesonide and antihistamines for the treatment of allergic rhinitis
AU2003254429A1 (en) * 2003-08-06 2005-02-25 Galephar M/F Advantageous combinations for inhalation of nacystelyn and bronchodilators
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
PL2522365T3 (en) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
AU2006224842B2 (en) * 2005-03-16 2011-09-29 Meda Pharma Gmbh & Co Kg The combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
EP1946752B1 (en) * 2005-08-26 2011-04-20 Meiji Dairies Corporation Anti-allergic agent
CA2657581A1 (en) 2006-07-11 2008-01-17 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
JP2008143845A (en) * 2006-12-11 2008-06-26 Hoshienu Seiyaku Kk Nasal drop composition and nasal drop spraying tool
AU2013266067B2 (en) * 2012-05-25 2016-10-06 Xlear, Inc. Xylitol-based anti-mucosal compositions and related methods and compositions
CN104667256B (en) * 2015-03-18 2017-05-03 江苏威克斯医疗科技有限公司 Nasal cavity mucosa cilium nursing flushing fluid and application thereof
CN107753485A (en) * 2017-11-28 2018-03-06 赵永宏 A kind of pharmaceutical composition for having nose congestion and anesthetic effect concurrently and its application

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
JPH0753671B2 (en) * 1985-12-26 1995-06-07 積水化学工業株式会社 Transdermal / transmucosal preparation
ES2137981T3 (en) * 1991-11-19 2000-01-01 Univ Virginia COMBINED TREATMENT BY ANTIMEDIATIC AND ANTIVIRIC AGENTS OF COMMON COLDS.
EP0719156A1 (en) * 1993-09-07 1996-07-03 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
WO1997001337A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
WO1997001341A1 (en) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
DE19532714A1 (en) * 1995-09-05 1997-03-06 Bayer Ag Combination of 5-lipoxygenase and leukotriene synthesis inhibitors with glucocorticosteroids
EP0780127A1 (en) * 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine

Also Published As

Publication number Publication date
JP2001524108A (en) 2001-11-27
CN1253508A (en) 2000-05-17
EP0979105A1 (en) 2000-02-16
AU6878098A (en) 1998-11-24
BR9809022A (en) 2000-08-01
CA2281789A1 (en) 1998-11-05
WO1998048839A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
IL131492A0 (en) Topical nasal antiinflammatory compositions
GB9726916D0 (en) Nasal formulation
ZA982748B (en) Dermatological composition
IL131415A0 (en) Anti-inflammatory compounds
PL341686A1 (en) Dermatological composition
HUP0100460A3 (en) Glucocorticoid-selective anti-inflammatory agents
ZA975902B (en) Topical composition
AU8747998A (en) Anti-inflammatory agent
ZA974266B (en) Anti-vaginitis compositions for topical use
AU7333398A (en) Nasal melatonin composition
AU2310395A (en) Topical retinal-based composition
ZA974126B (en) Topical composition
GB9606901D0 (en) Topical composition
GB9819994D0 (en) Topical preparation
AU1784899A (en) Nasal drop compositions
GB9612417D0 (en) A topical composition
GB9803005D0 (en) Anti-inflammatory agents
AU6128398A (en) New composition
AU697019B2 (en) Nasal spray compositions
ZA982752B (en) Composition for topical application
GB9811542D0 (en) Topical composition
AUPO850997A0 (en) Topical composition
AUPO851997A0 (en) Topical therapeutic compositions
AUPO703297A0 (en) Topical therapeutic compositions
GB2330432B (en) Calculator